The Niche Stem Cell & Regen Med Website

We have a new post today!

The Niche weekend reads: Editas mess, The Niche updates, papers

The news of the week relates to an interim clinical trial report from gene-editing firm Editas on its CRISPR trial for a form of vision loss. On to that in a minute. What have you been reading the past week? Below, I include our weekly list of recommended reads. However, first I wanted to give you a brief update on …
The Niche weekend reads: Editas mess, The Niche updates, papers